Drug Chatter -- Tracking biopharma stock chatter

Profile for Pluristem Therapeutics, Inc. (PSTI)

« Back to company index

PSTI Chatter Timeline

Stock Ticker for PSTI

Most Active Tweeters for PSTI

UserTweets
@dispatchtribune 6
@WeekHerald 5
@AmericanBanking 5
@TickerReport 4
@GantosJ 4

Recent Tweets for PSTI

registrarjourn @registrarjourn
Seaport Global Securities Equities Analysts Raise Earnings Estimates for Pluristem Therapeutics Inc. $PSTI https://t.co/gPASchCZRW
May 24th 2018, 6:05am
dispatchtribune @dispatchtribune
Seaport Global Securities Equities Analysts Raise Earnings Estimates for Pluristem Therapeutics Inc. $PSTI https://t.co/tOKcanJYTm
May 24th 2018, 1:05am
dailypoliticaln @dailypoliticaln
Brokerages Set Pluristem Therapeutics Inc. $PSTI Price Target at $4.00 https://t.co/9kCaUc843e
May 23rd 2018, 4:05pm
TickerReport @TickerReport
Pluristem Therapeutics Inc. $PSTI Given Average Rating of “Buy” by Analysts https://t.co/GaJfmNiYWc
May 23rd 2018, 4:05pm
WatchlistN @WatchlistN
Brokers Issue Forecasts for Pluristem Therapeutics Inc.’s FY2018 Earnings $PSTI https://t.co/7iergAB4pu
May 23rd 2018, 7:05am
etkoinc @etkoinc
RT @GantosJ: $PSTI still trading between 50Ma to 200MA.. looking for the next leg up as we get closer to mid-June for the IC results! https…
May 22nd 2018, 3:05pm
GantosJ @GantosJ
$PSTI still trading between 50Ma to 200MA.. looking for the next leg up as we get closer to mid-June for the IC res… https://t.co/chwaOyH07s
May 22nd 2018, 2:05pm
GantosJ @GantosJ
@vijay9933 $PSTI have 3 indication in the final stage of development, with a very close catalyst, IC results in Jun… https://t.co/8KHJ9hw2jO
May 22nd 2018, 10:05am
scientwest @scientwest
RT @GantosJ: Final FDA approval will allow $PSTI to sell to governments world-wide wishing to stockpile doses of PLX-R18 to guard against t…
May 22nd 2018, 8:05am
GantosJ @GantosJ
Final FDA approval will allow $PSTI to sell to governments world-wide wishing to stockpile doses of PLX-R18 to guar… https://t.co/0WPKRHmFst
May 22nd 2018, 8:05am
TranscriptDaily @TranscriptDaily
-$0.09 EPS Expected for Pluristem Therapeutics Inc. $PSTI This Quarter https://t.co/Z3XD3z6MrF
May 22nd 2018, 5:05am
AmericanBanking @AmericanBanking
-$0.09 EPS Expected for Pluristem Therapeutics Inc. $PSTI This Quarter https://t.co/FCCazrPlT8 #stocks
May 22nd 2018, 5:05am
ZolmaxNews @ZolmaxNews
Analysts Set Pluristem Therapeutics Inc. $PSTI Price Target at $4.00 https://t.co/aIn8wky6fj
May 21st 2018, 11:05am
ThisLincolnian @ThisLincolnian
Pluristem Therapeutics Inc. $PSTI Receives Consensus Rating of “Buy” from Analysts https://t.co/yHwNfih8dv
May 18th 2018, 6:05am
AmericanBanking @AmericanBanking
Pluristem Therapeutics Inc. $PSTI Receives Consensus Rating of “Buy” from Analysts https://t.co/HQ5zAQqPyq #stocks
May 18th 2018, 5:05am
dispatchtribune @dispatchtribune
Pluristem Therapeutics Inc. $PSTI Receives Consensus Rating of “Buy” from Analysts https://t.co/TM9HAS1d79
May 18th 2018, 5:05am
OlympiaReport @OlympiaReport
Pluristem Therapeutics Inc. $PSTI Given Consensus Recommendation of “Buy” by Brokerages https://t.co/ZELth9UHya
May 18th 2018, 5:05am
ThisLincolnian @ThisLincolnian
Recent Analysts’ Ratings Changes for Pluristem Therapeutics $PSTI https://t.co/D7pkO8EVcO
May 17th 2018, 6:05am
AmericanBanking @AmericanBanking
Recent Analysts’ Ratings Changes for Pluristem Therapeutics $PSTI https://t.co/bfTjK0lsVC #stocks
May 17th 2018, 3:05am
dispatchtribune @dispatchtribune
Recent Analysts’ Ratings Changes for Pluristem Therapeutics $PSTI https://t.co/XnNWAaiuic
May 17th 2018, 3:05am
TickerReport @TickerReport
Bio-Techne $TECH and Pluristem Therapeutics $PSTI Financial Survey https://t.co/ubRXY3V9c5
May 15th 2018, 2:05pm
dispatchtribune @dispatchtribune
Pluristem Therapeutics $PSTI Given a $4.00 Price Target by HC Wainwright Analysts https://t.co/4qU8ailooJ
May 15th 2018, 5:05am
OlympiaReport @OlympiaReport
HC Wainwright Analysts Give Pluristem Therapeutics $PSTI a $4.00 Price Target https://t.co/dGPm7RvWGy
May 14th 2018, 11:05am
WeekHerald @WeekHerald
HC Wainwright Analysts Give Pluristem Therapeutics $PSTI a $4.00 Price Target https://t.co/yao7H5fnq9
May 14th 2018, 6:05am
dakotafinancial @dakotafinancial
Pluristem Therapeutics $PSTI PT Set at $3.00 by Maxim Group https://t.co/vH3lr1qdNU
May 14th 2018, 5:05am
ZolmaxNews @ZolmaxNews
Pluristem Therapeutics $PSTI PT Set at $3.00 by Maxim Group https://t.co/LbDbnjoIvQ
May 14th 2018, 5:05am
TranscriptDaily @TranscriptDaily
Pluristem Therapeutics $PSTI Getting Positive News Coverage, Accern Reports https://t.co/vxCsZem2fZ
May 13th 2018, 5:05pm
TranscriptDaily @TranscriptDaily
Pluristem Therapeutics $PSTI and Bio-Techne $TECH Head to Head Contrast https://t.co/kfZYT9nXRz
May 13th 2018, 4:05pm
TheMarketsDaily @TheMarketsDaily
Maxim Group Analysts Give Pluristem Therapeutics $PSTI a $3.00 Price Target https://t.co/bA8fHQRcVO
May 13th 2018, 1:05pm
WatchlistN @WatchlistN
Pluristem Therapeutics $PSTI PT Set at $4.00 by HC Wainwright https://t.co/d4sWQ3jDBs
May 13th 2018, 11:05am
WeekHerald @WeekHerald
Pluristem Therapeutics $PSTI and Bio-Techne $TECH Head to Head Contrast https://t.co/HfACoCnMwC
May 13th 2018, 10:05am
ledgerzette @ledgerzette
Pluristem Therapeutics $PSTI PT Set at $4.00 by HC Wainwright https://t.co/aLf08uNht1
May 13th 2018, 7:05am
dakotafinancial @dakotafinancial
Pluristem Therapeutics $PSTI Releases Earnings Results, Beats Estimates By $0.08 EPS https://t.co/M0AWksyWPD
May 12th 2018, 6:05pm
TheMarketsDaily @TheMarketsDaily
Pluristem Therapeutics $PSTI Announces Quarterly Earnings Results, Beats Estimates By $0.08 EPS https://t.co/C5k9Ni5KTK
May 12th 2018, 6:05pm
WatchlistN @WatchlistN
Maxim Group Analysts Give Pluristem Therapeutics $PSTI a $3.00 Price Target https://t.co/o8JTVhNX9f
May 12th 2018, 3:05pm
TickerReport @TickerReport
Pluristem Therapeutics $PSTI Given a $4.00 Price Target at HC Wainwright https://t.co/Vu8Xh83u2f
May 12th 2018, 3:05pm
dailypoliticaln @dailypoliticaln
HC Wainwright Analysts Give Pluristem Therapeutics $PSTI a $4.00 Price Target https://t.co/HCMtpe70uD
May 12th 2018, 3:05pm
registrarjourn @registrarjourn
Pluristem Therapeutics $PSTI Given a $4.00 Price Target at HC Wainwright https://t.co/yPlyKIbwJD
May 12th 2018, 3:05pm
WeekHerald @WeekHerald
Pluristem Therapeutics $PSTI Releases Earnings Results, Beats Estimates By $0.08 EPS https://t.co/2JZmzyWAkp
May 12th 2018, 10:05am
ConsumerFeed @ConsumerFeed
Pluristem Therapeutics $PSTI Issues Earnings Results https://t.co/doI7SR5yfB
May 12th 2018, 12:05am
EnterpriseLeade @EnterpriseLeade
Pluristem Therapeutics $PSTI Posts Earnings Results, Beats Expectations By $0.08 EPS https://t.co/xV7H6KlPzr
May 12th 2018, 12:05am
dispatchtribune @dispatchtribune
Pluristem Therapeutics $PSTI Issues Earnings Results, Beats Estimates By $0.08 EPS https://t.co/x2EYCGtvW1
May 12th 2018, 12:05am
ledgerzette @ledgerzette
Pluristem Therapeutics $PSTI Posts Earnings Results, Beats Expectations By $0.08 EPS https://t.co/qb5OB9xe2n
May 12th 2018, 12:05am
AmericanBanking @AmericanBanking
Pluristem Therapeutics $PSTI Posts Earnings Results, Beats Expectations By $0.08 EPS https://t.co/VuRCpYHde1 #stocks
May 11th 2018, 10:05pm
ZolmaxNews @ZolmaxNews
Pluristem Therapeutics $PSTI Posts Earnings Results, Beats Expectations By $0.08 EPS https://t.co/6QnQmHu5Z6
May 11th 2018, 10:05pm
ThisLincolnian @ThisLincolnian
Pluristem Therapeutics $PSTI Posts Earnings Results, Beats Expectations By $0.08 EPS https://t.co/stk4eITJgu
May 11th 2018, 10:05pm
dispatchtribune @dispatchtribune
Zacks: Brokerages Anticipate Pluristem Therapeutics Inc. $PSTI to Post -$0.08 Earnings Per Share https://t.co/k2EiCdJyDa
May 11th 2018, 6:05pm
OlympiaReport @OlympiaReport
Pluristem Therapeutics Inc. $PSTI Expected to Announce Earnings of -$0.08 Per Share https://t.co/fN1f9QCelF
May 11th 2018, 6:05pm
AmericanBanking @AmericanBanking
Pluristem Therapeutics $PSTI Earns “Buy” Rating from HC Wainwright https://t.co/NQxjPrMw6N #stocks
May 11th 2018, 5:05pm
WeekHerald @WeekHerald
Pluristem Therapeutics $PSTI Given a $3.00 Price Target by Maxim Group Analysts https://t.co/hpVvegg67S
May 11th 2018, 5:05pm

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.